• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Letter to the editor: "Frequency of zoledronate administration in early breast cancer".

作者信息

Tang Wei-Zhen, Deng Wen-Xing, Liu Tai-Hang

机构信息

Department of Bioinformatics, School of Basic Medical Sciences, Chongqing Medical University, No.1 Yixueyuan Rd, Box 197, Chongqing, 400016, China.

出版信息

Breast Cancer Res Treat. 2024 Dec;208(3):689-690. doi: 10.1007/s10549-024-07490-9. Epub 2024 Sep 4.

DOI:10.1007/s10549-024-07490-9
PMID:39230628
Abstract
摘要

相似文献

1
Letter to the editor: "Frequency of zoledronate administration in early breast cancer".致编辑的信：“早期乳腺癌中唑来膦酸的给药频率”
Breast Cancer Res Treat. 2024 Dec;208(3):689-690. doi: 10.1007/s10549-024-07490-9. Epub 2024 Sep 4.
2
Does the number of 6-monthly adjuvant zoledronate infusions received affect treatment efficacy for early breast cancer? A sub-study of ABCSG-12.接受每6个月一次的辅助唑来膦酸输注次数是否会影响早期乳腺癌的治疗效果？ABCSG-12的一项子研究。
Eur J Cancer. 2023 Feb;180:108-116. doi: 10.1016/j.ejca.2022.12.003. Epub 2022 Dec 10.
3
A randomised trial comparing 6-monthly adjuvant zoledronate with a single one-time dose in patients with early breast cancer.一项比较早期乳腺癌患者 6 个月辅助唑来膦酸和单次剂量的随机试验。
Breast Cancer Res Treat. 2024 Dec;208(3):523-533. doi: 10.1007/s10549-024-07443-2. Epub 2024 Jul 31.
4
Natural history of stage II/III breast cancer, bone metastasis and the impact of adjuvant zoledronate on distribution of recurrences.II/III期乳腺癌的自然病史、骨转移以及辅助性唑来膦酸对复发分布的影响。
J Bone Oncol. 2021 May 4;28:100367. doi: 10.1016/j.jbo.2021.100367. eCollection 2021 Jun.
5
Zoledronate for patients with invasive residual disease after anthracyclines-taxane-based chemotherapy for early breast cancer - The Phase III NeoAdjuvant Trial Add-oN (NaTaN) study (GBG 36/ABCSG 29).早期乳腺癌蒽环类-紫杉烷类化疗后侵袭性残留疾病患者使用唑来膦酸——III期新辅助试验附加研究（NaTaN）（GBG 36/ABCSG 29）
Eur J Cancer. 2016 Sep;64:12-21. doi: 10.1016/j.ejca.2016.05.015. Epub 2016 Jun 17.
6
Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results.唑来膦酸（唑来膦酸盐）用于接受辅助来曲唑治疗的绝经后早期乳腺癌女性（ZO-FAST 研究）：最终 60 个月结果。
Ann Oncol. 2013 Feb;24(2):398-405. doi: 10.1093/annonc/mds277. Epub 2012 Oct 9.
7
VEGFA Involves in the Use of Fluvastatin and Zoledronate Against Breast Cancer.血管内皮生长因子A（VEGFA）参与氟伐他汀和唑来膦酸对乳腺癌的治疗作用。
Pathol Oncol Res. 2018 Jul;24(3):557-565. doi: 10.1007/s12253-017-0277-4. Epub 2017 Jul 25.
8
Letter to the Editor From Fitzpatrick et al: "Zoledronate After Denosumab Discontinuation: Is Repeated Administrations More Effective Than A Single Infusion?".致编辑的信 来自菲茨帕特里克等人：“地诺单抗停药后使用唑来膦酸：重复给药比单次输注更有效吗？”
J Clin Endocrinol Metab. 2024 Nov 18;109(12):e2358-e2359. doi: 10.1210/clinem/dgae491.
9
Response to: Letter to the Editor From Fitzpatrick et al: "Zoledronate After Denosumab Discontinuation: Is Repeated Administrations More Effective Than Single Infusion?".对菲茨帕特里克等人致编辑的信的回复：“停用地诺单抗后使用唑来膦酸：重复给药比单次输注更有效吗？”
J Clin Endocrinol Metab. 2024 Nov 18;109(12):e2360-e2361. doi: 10.1210/clinem/dgae493.
10
Feasibility outcomes of a randomised, multicentre, pilot trial comparing standard 6-monthly dosing of adjuvant zoledronate with a single one-time dose in patients with early stage breast cancer.一项随机、多中心、试点试验的可行性结果，该试验比较了早期乳腺癌患者辅助唑来膦酸标准每6个月给药一次与单次给药的效果。
J Bone Oncol. 2020 Dec 13;26:100343. doi: 10.1016/j.jbo.2020.100343. eCollection 2021 Feb.

本文引用的文献

1
A randomised trial comparing 6-monthly adjuvant zoledronate with a single one-time dose in patients with early breast cancer.一项比较早期乳腺癌患者 6 个月辅助唑来膦酸和单次剂量的随机试验。
Breast Cancer Res Treat. 2024 Dec;208(3):523-533. doi: 10.1007/s10549-024-07443-2. Epub 2024 Jul 31.
2
Adjuvant bisphosphonate use in patients with early stage breast cancer: a physician survey.早期乳腺癌患者辅助双膦酸盐的应用：一项医师调查。
Breast Cancer Res Treat. 2021 Jun;187(2):477-486. doi: 10.1007/s10549-021-06147-1. Epub 2021 Mar 23.
3
Feasibility outcomes of a randomised, multicentre, pilot trial comparing standard 6-monthly dosing of adjuvant zoledronate with a single one-time dose in patients with early stage breast cancer.
一项随机、多中心、试点试验的可行性结果，该试验比较了早期乳腺癌患者辅助唑来膦酸标准每6个月给药一次与单次给药的效果。
J Bone Oncol. 2020 Dec 13;26:100343. doi: 10.1016/j.jbo.2020.100343. eCollection 2021 Feb.